サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1588572

薬としての食品（Food as a Medicine）の世界市場：2024年～2031年

Global Food as a Medicine Market - 2024-2031

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
薬としての食品（Food as a Medicine）の世界市場：2024年～2031年
出版日: 2024年11月08日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

薬としての食品（Food as a Medicine）の世界市場は、2023年に47億1,000万米ドルに達し、2031年には115億1,000万米ドルに達すると予測され、予測期間2024～2031年のCAGRは12.2%で成長する見込みです。

薬としての食品とは、疾病の症状を予防、軽減、または防止するために、個人の健康計画において食品と食事を優先させることを指します。健康管理に対する「薬としての食品」のアプローチは、医薬品を使用して健康や病気を治療するための技術的な医学開発に主に依存する従来の医学の基盤に課題するものです。薬としての食品」を使用することで、検査結果の改善、薬剤の削減、入院回数の減少を通じて、病気の重症度を軽減できる可能性があり、ヘルスケア費用を削減できるかもしれないです。

多くの教養と知識を持った消費者は、薬やその他の治療を含む薬物療法よりも、薬としての食品を好みます。例えば、2023年5月の食品安全ネットサービス（FSNS）の調査によると、顧客の55%は薬として機能し、健康と幸福を改善する食品に割高な料金を支払うことを望んでいます。

市場力学：

促進要因と阻害要因

慢性疾患の有病率の上昇

慢性疾患の有病率の増加は、薬としての食品（Food as a Medicine）市場の成長を著しく促進しており、市場予測期間を通じてその牽引役となることが予想されます。人々の健康意識が高まるにつれて、人々は薬としての食品（Food as a Medicine）のアプローチを採用することで、疾病を予防し、免疫力を高め、進行中の疾病を管理し、全般的な健康状態を改善する方法を積極的に模索するようになっています。その結果、食品はこうした健康目標を達成するための重要な要素と見なされるようになってきています。

抗炎症食品、心血管代替食品、抗老化栄養、解毒食など、さまざまな食事戦略が、栄養補助食品として、また現代医療の必須要素として人気を集めています。こうした意識の高まりは、個人を食品中心の解決策へとシフトさせており、慢性疾患を管理し回避するための自然で持続可能かつ効果的な方法を人々が求めるようになるにつれて、今後も続くと予想されます。伝統的なヒーリング・フードは、その性質と副作用のなさから需要が高まっています。

例えば、2024年の国立衛生研究所によると、糖尿病の有病率は2030年までに6億4,300万人に達すると予想されており、これは主に発展途上国における150%の増加によるものです。インド、中国、米国、インドネシア、日本、パキスタン、ロシア、ブラジル、イタリア、バングラデシュが糖尿病罹患率の高い国です。糖尿病は世界的に深刻な健康問題であると認識されています。糖尿病患者は、高所得国よりも中低所得国の方がはるかに速いペースで増加しています。

がんの罹患率が高まる中、健康リスクを減らし、食品を薬として利用するための疾病予防アプローチとして、食品に注目が集まっています。食品とがん予防の関係はより単純になりつつあり、抗がん作用の可能性がある食品がいくつか確認されています。世界中でがんの数が増加する中、人々は病気を悪化させる可能性を最小限に抑えることができる食品に注目しています。心血管疾患が世界の死亡原因の上位を占めていることから、食品による心血管サポートは薬としての食品（Food as a Medicine）市場の重要な構成要素となっています。

薬としての食品（Food as a Medicine）に関する個人の限られた認識

薬としての食品（Food as a Medicine）のアプローチに対する認識が限定的であることが、薬としての食品（Food as a Medicine）市場の成長の妨げになると予想されます。多くの人々が、多くの疾病を予防し治癒する持続可能な方法で生産された食品の健康面および環境面での利点に気づいていないです。こうした認識不足のため、生産者は、より健康的で有機的、または環境に優しい製品に関心を持つ可能性のある個人を惹きつけることができないです。そのメリットを十分に理解しないまま、顧客は薬としての食品よりも、より身近で手頃だと思われる従来型の食品を選んでしまうのです。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 慢性疾患の増加
    • 抑制要因
      • 薬としての食品（Food as a Medicine）に関する個人の意識の低さ
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • 償還分析
  • 特許分析
  • SWOT分析
  • DMIオピニオン

第6章 製品タイプ別

  • 栄養補助食品
  • 機能性食品と飲料
  • 医療用食品
  • ホールフーズ・ナチュラルフーズ

第7章 形状別

  • カプセル
  • 錠剤
  • 粉末
  • 液体
  • バー

第8章 用途別

  • 心血管
  • アンチエイジング
  • デトックス
  • 栄養不足
  • 糖尿病
  • 抗がん
  • その他

第9章 流通チャネル別

  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • ドラッグストア
  • スーパーマーケット

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Bionova
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Nestle
  • Primus Pharmaceuticals, Inc.
  • Season Health
  • Mead Johnson & Company, LLC.
  • SFI Health
  • Metagenics
  • Meiji Holdings Co., Ltd.
  • Bitewell
  • Mealogic

第13章 付録

目次
Product Code: OT8707

Overview

Global food as a medicine market reached US$ 4.71 billion in 2023 and is expected to reach US$ 11.51 billion by 2031, growing at a CAGR of 12.2 % during the forecast period 2024-2031.

Food as a medicine refers to prioritizing food and diet in an individual's health plan to prevent, reduce, or prevent disease symptoms. The "food as a medicine" approach to health management challenges the foundation of conventional medicine, which depends primarily on technological medical developments to treat health and disease using pharmaceutical medications. Using "food as a medicine" may lower healthcare expenses by potentially reducing illness severity through improved labwork, fewer drugs, and fewer hospitalizations.

A large number of educated and knowledged consumers prefer food as a medicine approach over medications which includes drugs and other treatments. For instance, according to a study by the Food Safety Net Services (FSNS) in May 2023, 55% of customers are willing to pay a premium for food that can act as medicine, improving their health and well-being.

Market Dynamics: Drivers & Restraints

Rising prevalence of chronic diseases

The increasing prevalence of chronic diseases is significantly driving the growth of the food as a medicine market and is expected to drive throughout the market forecast period. As people are becoming more health conscious, they are actively looking for ways to prevent illnesses, increase immunity, manage ongoing illness, and improve their general well-being by adopting food as a medicine approach. As a result, food is increasingly regarded as a critical component in accomplishing these health goals.

Various dietary strategies, such as anti-inflammatory foods, cardiovascular alternatives, anti-aging nutrition, and detoxifying diets are gaining popularity as supplementary therapies and as essential components of modern healthcare procedures. This increasing awareness is shifting individuals toward food-centric solutions and is expected to continue as people seek natural, sustainable, and effective ways to manage and avoid chronic conditions. Traditional healing foods are gaining demand due to their nature and with no side effects.

For instance, according to the National Institute of Health in 2024, the prevalence of diabetes is expected to reach 643 million by 2030, which is mainly due to a 150% increase in developing nations. India, China, the United States, Indonesia, Japan, Pakistan, Russia, Brazil, Italy, and Bangladesh are the countries with the highest diabetes rates. Diabetes has been identified as a serious worldwide health concern. Diabetes cases are growing at a far faster rate in low- and middle-income countries than in high-income countries.

With the increasing prevalence of cancer, there is an increasing focus on food as a disease prevention approach to reduce health risks and use food as a medicine. The relationship between food and cancer prevention is becoming simpler, with several foods being identified as having potential anti-cancer effects. As the number of cancers increases around the world, people are turning to food that can help minimize their chance of worsening the disease. With cardiovascular disease as one of the top causes of mortality worldwide, cardiovascular support through food has become an important component of the food as medicine market.

Limited awareness among individuals about food as a medicine

Limited awareness of food as a medicine approach is expected to hinder food as a medicine market growth. A large proportion of people are unaware of the health and environmental benefits of sustainably produced foods which prevent and cure a large number of illnesses. Because of this lack of awareness, producers fail to attract individuals who may otherwise be interested in healthier, organic, or environmentally friendly products. Without an adequate understanding of the benefits, customers choose conventional food products that they believe to be more familiar and affordable over food as a medicine approach.

Segment Analysis

The global food as a medicine market is segmented based on product type, form, application, distribution channel and region.

Medical Foods segment is expected to dominate the food as a medicine market share

The medical foods segment holds a major portion of the food as a medicine market share and is expected to continue to hold a significant portion of the food as a medicine market share during the forecast period. Medical foods differ from the broader category of foods for special dietary use in that they are intended to meet the unique nutritional requirements of a disease or condition, must be used under medical supervision, and are intended for the specific dietary management of a disease or condition.

The segment is expected to dominate the food as a medicine market share due to the increasing awareness among individuals about nutritional therapies rather than completely depending on drugs to cure the disease. A wide range of medical foods with different compositions and various applications are being introduced by the food as a medicine market players which are contributing to the segment expansion.

A large number of key players are adopting strategies to increase production capacity and expand their businesses which is expected to drive the segment's expansion. With these strategies, companies are expanding their portfolios and penetrating other regions, which is driving the segment's growth and is expected to hold the major share in the food as medicine market.

For instance, in September 2024, Dutch Medical Food B.V. made its official entry into the Indian market via a strategic relationship with Pristine Pearl Pharma Pvt. Ltd. This collaboration represents the introduction of an innovative line of products to treat disease-related malnutrition in both adult and pediatric populations. The latest offerings are primarily targeted at illnesses such as cancer, pediatric malnutrition, COPD, and drug-resistant epilepsy, to considerably improve health outcomes across India.

Similarly, in August 2024, Avesthagen Ltd and Apollo AyurVAID formed a strategic partnership to manufacture and market medical foods and dietary supplements. Following the collaboration, Avesthagen Ltd and Apollo AyurVAID will combine their skills and knowledge to design, manufacture, and market precision medical foods based on new tactics that improve patient care and promote holistic well-being.

Geographical Analysis

North America is expected to hold a significant position in the food as a medicine market share

North America holds a substantial position in the food as medicine market and is expected to hold most of the market share. This is due to the growing demand for foods and diet over medicine in the region with the increasing awareness among individuals. The increasing number of chronic diseases in the region is raising the demand for food-based therapies. There is a rising approach to food as a medicine that can be personalized.

The government bodies in the region are hosting summits and taking initiatives to increase awareness among individuals on food as medicine approaches. For instance, on January 31, 2024, the U.S. Department of Health and Human Services (HHS) hosted its first-ever Food is Medicine Summit in Washington, D.C., an all-day summit for stakeholders at the intersection between food and health. Secretary Xavier Becerra opened the summit by announcing three new public-private partnerships with Instacart, the Rockefeller Foundation, and Feeding America. All three partnerships will support HHS's nutrition goals.

Additionally, market players in the region are introducing advanced products of food as medicine and they are introducing new platforms to make the products available for all the individuals seeking these food-based treatments. These market players are expanding their businesses by adopting various strategies such as partnerships with each other and launching new products to make them meet the rising demand.

For instance, on August 26, 2024, Good Measures and Point32Health partnered to offer personalized nutrition support to members of Harvard Pilgrim Health Care, one of Point32Health's two insurance subsidiaries. The initiative provides nutrition counseling, food tracking, and other services through the Good Measures app, targeting conditions such as diabetes, heart disease, and obesity.

Similarly, on 16 Jul 2024, Season Health partnered with Mealogic at launch to deliver nutritionally tailored, culturally diverse meals to their patients. Mealogic has consistently provided low-cost, high-quality meals that have driven program adoption and delivered measurable clinical results nationwide.

There is an increasing shift and trend towards self-care through nutrition-based foods in the region which is also expected to contribute to the region's food as a medicine market share. Thus, with various strategies by the market players, increasing initiatives by the government bodies and the increasing incidence of chronic diseases, the food as a medicine market is expected to grow and the region is expected to dominate the global food as a medicine market share.

Market Segmentation

By Product Type

  • Dietary Supplements
  • Functional Foods and Beverages
  • Medical Foods
  • Whole Foods and Natural Foods

By Form

  • Capsules
  • Tablets
  • Powders
  • Liquid
  • Bars

By Application

  • Cardiovascular
  • Anti-Aging
  • Detoxification
  • Nutritional Deficiency
  • Diabetes
  • Anti-Cancer
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
  • Supermarkets

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the food as a medicine market include Bionova, Nestle, Primus Pharmaceuticals, Inc., Season Health, Mead Johnson & Company, LLC., SFI Health, Metagenics, Meiji Holdings Co., Ltd., Bitewell and Mealogic among others.

Key Developments

  • In April 2024, Vevolution, an Agrifoodtech investment platform, announced that it will organize a virtual pitch event themed "Food as Medicine". The sector is quickly gaining investment interest and encompasses areas like personalized nutrition, functional ingredients, sugar and salt alternatives, and microbiome health.
  • In March 2023, Instacart Health introduced tools for scaling 'Food as Medicine' programs. Healthcare professionals can now use Instacart's suite of digital technologies to improve collaborative care, promote healthy choices, and provide nutritious food to patients and their families, especially those who live in food deserts or require a medically restricted diet.

Why Purchase the Report?

  • To visualize the global food as a medicine market segmentation based on product type, form, application, distribution channel, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of food as a medicine market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global food as a medicine market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Form
  • 3.3. Snippet by Application
  • 3.4. Snippet by Distribution Channel
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising prevalence of chronic diseases
    • 4.1.2. Restraints
      • 4.1.2.1. Limited awareness among individuals about food as a medicine
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Patent Analysis
  • 5.7. SWOT Analysis
  • 5.8. DMI Opinion

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Dietary Supplements*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Functional Foods and Beverages
  • 6.4. Medical Foods
  • 6.5. Whole Foods and Natural Foods

7. By Form

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 7.1.2. Market Attractiveness Index, By Form
  • 7.2. Capsules*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Tablets
  • 7.4. Powders
  • 7.5. Liquid
  • 7.6. Bars

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cardiovascular*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Anti-Aging
  • 8.4. Detoxification
  • 8.5. Nutritional Deficiency
  • 8.6. Diabetes
  • 8.7. Anti-Cancer
  • 8.8. Others

9. By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel
  • 9.2. Hospital Pharmacies*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Retail Pharmacies
  • 9.4. Online Pharmacies
  • 9.5. Drug Stores
  • 9.6. Supermarkets

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
      • 10.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
      • 10.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      • 10.2.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.3.1. The U.S.
      • 10.2.3.2. Canada
      • 10.2.3.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
      • 10.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
      • 10.3.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.4.1. Germany
      • 10.3.4.2. UK
      • 10.3.4.3. France
      • 10.3.4.4. Italy
      • 10.3.4.5. Spain
      • 10.3.4.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
      • 10.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
      • 10.4.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.4.1. Brazil
      • 10.4.4.2. Argentina
      • 10.4.4.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
      • 10.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
      • 10.5.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.4.1. China
      • 10.5.4.2. India
      • 10.5.4.3. Japan
      • 10.5.4.4. South Korea
      • 10.5.4.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
      • 10.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      • 10.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
      • 10.6.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Bionova*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Nestle
  • 12.3. Primus Pharmaceuticals, Inc.
  • 12.4. Season Health
  • 12.5. Mead Johnson & Company, LLC.
  • 12.6. SFI Health
  • 12.7. Metagenics
  • 12.8. Meiji Holdings Co., Ltd.
  • 12.9. Bitewell
  • 12.10. Mealogic

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us